Interleukin 5 (IL-5), the major factor involved in eosinophil differentiation, is produced by T cells or mast cells. In the present study, we found that eosinophils infiltrating the mucosa of four patients with active coeliac disease also express the Ib5 mRNA. No positive signal was obtained in normal duodenum tissues and in the cell infiltrate from patients submitted to gluten restriction. The identification of labeled mucosal cells as eosinophils relied on their typical morphology. Moreover, highly purified blood eosinophils from three out of four patients with eosinophilia were also strongly labeled with the Ib5 antisense but not with the corresponding sense probe. Together, these results suggest that eosinophils have the capacity to synthesize IL-5, which could contribute to paracrine interactions with T and B cells and, in autocrine fashion, locally partidpate, through binding to the Ib5 receptor, to eosinophil differentiation and activation. These data might have implications not only in the pathology of coeliac disease but also in other diseases associated with eosinophil infiltration.
I
L-5 supports the proliferation and terminal differentiation of eosinophilic precursors (1) as well as the prolonged survival of eosinophils in vitro (2) . It is also a potent activator of eosinophil functions such as cytotoxicity or mediator release (3) . The effects of IL-5 on B cells and Ig synthesis have been studied in more detail in rodents. Both human and mouse II.-5 and Ib6 enhance in vitro IgA secretion from isolated routine cells of mucosal origin (4) . More recently, it has been reported that both IL-5 and IL-6 augment local IgA production in vivo, in the tears of rats (5) . However, the effect of IL-5 on human B cells remains controversial (6) .
Coeliac disease (CD) is defined as a gluten-sensitive enteropathy that results in intestinal damage with varying degrees of villous atrophy. Morphometric studies have shown that the eosinophil population is markedly expanded in the CD mucosa and diminished under gluten restriction (7) . Another feature of CD is a dense infiltration of the jejunum by IgAsecreting plasma cells and an enhanced production of secretory IgA antibodies (8) .
By in situ hybridization, ID5 messenger RNA (mRNA) was detected in skin and mucosal bronchial biopsies of patients with eosinophil infiltration, but without identification of the labeled cells (9, 10) . In the present study, we analyze by a similar approach the expression of ID5 mRNA in duodenojejunal mucosa from patients with CD. Our results show the presence of ID5 mRNA in eosinophils and suggest that II,5, classically produced by T cells, can arise from eosinophils and participate to eosinophil activation in CD, as well as in other diseases.
Materials and Methods
Tusue/~ess/n&. Biopsy specimens were collected by endoscopy from the terminal duodenum of four patients with clinically active GD. The biopsies showed crypt byperphsia and tom villous atrophy. In two of these patients, biopsy specimens were also obtained endoscopic.ally at an inactive phase of the disease after treatment by gluten restriction. Negative controls were samples of normal duodenum obtained during investigation of three patients with functional abdominal pain. Intestinal fragments were properly oriented, fixed immediately in fresh 4% paraformaldehyde/PBS, and processed for paraffin embedding by standard techniques.
Cell Preparations. Eosinophils were purified from the blood of four patients with ensinophilia of ditfcmat etiologies: Hodgkin's disease, idiopathic hypereosinophih'c syndrome, systemic mastocytoffs, and episodic angioedema. A technique of centrifugation on discontinuous metrizamide gradients was used as previously de-scribed (11) . Activated hypodense eosinophils, which sediment in the low density layers, were collected. The degree of eosinophil purity was evaluated by May Grfinwald Giemsa differential counting on cytocentrifuged preparations and reached between 75% and 95% eosinophils. These cells were resuspended at a concentration of 0.8 x 10 ~ cells/ml of HBSS and loaded on gelatin-coated slides (0.8 x 10 s cells/slide) by cytocentrifugation. The cytopreparations were immediately fixed for 20 rain in 4% paraformaldehyde and stored at -20~ before being analyzed by in situ hybridization.
Preparation of Labeled Probes. The cDNA for human Ib5 and IL-6 were subdoned into the Blue Script vector by standard techniques. Linearized plasmids were used as templates for the synthesis in vitro of 3SS-labehd KNA probes complementary to the cellular IL mKNA (antisense probes). RNA was also transcribed from the opposite direction and used as a negative control (sense probes).
In Situ Hybn'dization. For a given KNA, antisense or sense probes (4,150 cpm/mm 2) were used and hybridization was performed with duodenojejunal biopsies and controls as previously described (12) . To inhibit the nonspecific binding of 3sS, tissues and cells were acetylated in triethanolamine (0.1 M) for 5 min and then in acetic anhydride, 0.25% triethanolamine for 10 min. Then, to avoid nonspecific binding to eosinophils, prehybridization was carried out with a solution containing a nonradiohbeled S-UTP irrelevant probe for at least 2 h at 42~ DTT was added to the hybridization buffer, and KNAse A was used for posthybridization washings (13) . After development of the emulsion, tissue sections or cytospin preparations were then stained with May Griinwald Giemsa or Hoechst for examination in bright or dark field illumination, respectively.
Results and Discussion
In situ hybridization, using a 3sS-labeled antisense I1.5 RNA as the probe, revealed that numerous cells infiltrating the mucosa of patients with active CD highly express I1-5 mRNA. The results of one patient are shown in Fig. 1 A; however, a similar label intensity was obtained in the mucosa of the three other patients. Dark field illumination (Fig. 1 B) confirmed the strong level of hybridization and indicated that the positive hybridization signal was mainly located around the crypts. Examination of the tissues at a higher magnification revealed that the majority of eosinophils infiltrating active CD mucosae were significantly labeled with the I1-5 antisense probe (Fig. 1 C) . The presence of eosinophils in the tissue samples was detected by immunohistochemical analysis with the mAb EG2, which is directed against eosinophil cationic protein (14), on serial sections of each biopsy (data not shown). Moreover, a reduced time of incubation before development was used in order to more precisely identify the labeled cells, eosinophils being characterized by their bilobed nuclei (Fig.  1 D) . Very interestingly, no positive signal was detected with the Ib5 antisense probe in the mucosa during remission stage of the disease, although infiltrating eosinophils were present (Fig. 1 E) . Similar negative results were obtained in normal duodenum samples. The absence of hybridization signal, in active CD patients, with the 3sS-labeled I1-5 sense probe (Fig. 1 F) as well as with II,-6 sense or antisense probes (not shown) indicated that binding of the I1-5 antisense probe was specific. Since the identification of eosinophils relied on morphologic criteria alone, we wanted to gain further evidence that eosinophils can express I1.5 mRNA. Therefore, highly purified blood eosinophils (up to 95% purity), were also studied by in situ hybridization. The majority of eosinophils from three out of four patients spontaneously expressed Ib5 mRNA (Fig. 1 G) with the highest level of expression in eosinophils from a patient with the hypereosinophilic syndrome, whereas no hybridization was detected on eosinophils from a patient with episodic angioedema. No positive signal was detected with the control Ib5 sense probe on purified blood eosinophils from any of these patients (Fig. 1 H) .
Previous reports have established that I1.5 mRNA expression, regarded as being characteristic of activated T cells, can be detected in cell populations like mast cells (15) or ReedSternberg cells (16) . The present data indicate that human eosinophils, which have been reported to produce TGF-c~ (13), can also synthesize IbS. It is interesting to note that in all cases, eosinophils from tissues or peripheral blood that expressed Ib5 mtLNA were activated. This state of activation was suggested by the altered morphological appearance of eosinophils detected in the tissues during CD by electron microscopy (17) . In the case of the blood eosinophils, the selected hypodense populations correspond to the activated phenotype, previously characterized by immunological and biochemical properties (11) .
These new findings raise the possibility that expression by eosinophils of Ib5 mRNA might result from an activation process due to cell interaction or release of mediators in situ. It has been recently reported that expression of TGF-o~ by eosinophils might be under microenvironmental regulation (13) . It will clearly be of interest to search for the factors that influence the expression of IIr mRNA by eosinophils. Among these, cytokines or growth factors, as well as antibodies, might be involved. It is known that different regulatory mechanisms exist in mast cells for the transcription of differents groups of cytokines; in this model, increased levels of II-5 mRNA are obtained by IgE-anti-IgE stimulation (15) .
The identification of I1-5 mRNA, which provides evidence of gene expression by eosinophils, suggests but does not prove active synthesis of I1-5. Preliminary results using an 11-5-dependent cell line indicate that 99% pure eosinophils can secrete a significant amount of I1-5 (up to 3 U/2 x 106 cells). Taken together, these results provide evidence for the cellular localization of I1-5 mRNA in activated eosinophils, suggesting another role for eosinophils in the immune response. I1.5 can contribute to paracrine interactions with T and B cells. In CD, the local secretion of I1.5 can explain, at least in part, the enhanced synthesis of IgA. Autocrine effects of I1-5 can also be discussed, since I1-5 membrane receptors have been described, specially expressed on hypodense blood and tissue eosinophils (18) . An enhanced secretion of I1-5 might influence the local stimulation of eosinophil proliferation, differentiation, and activation. In addition, the eosinophil infiltrate observed in CD might be due to the effects of I1-5 on eosinophil adhesion molecules recently described (19) . Two recent reports have suggested the production of granulocyte/macrophage colony-stimulating factor and I1-3 by peripheral blood eosinophils, but only after in vitro stim- We thank Drs. D. Turck and J. P. Farriaux (Department of Pediatrics, C H U Lille, France). We are also grateful to Ms. M. J. Truong for help in the experimental procedure and to Drs. R. Lafyatis and J. C. Ameisen for helpful suggestions.
